Clinical Pharmacology & Therapeutics geht zu Nature

The American Society for Clinical Pharmacology and Therapeutics (ASCPT) and Nature Publishing Group (NPG) are pleased to announce a new publishing partnership. Starting in January 2007, NPG will publish the Society’s journal, Clinical Pharmacology & Therapeutics (vormals bei Elsevier) – the most cited journal publishing original research in pharmacology. At that time, the journal will be re-launched with a new editor and editorial team. We will watch prices! Fernglas

Institutional Journal Costs in an Open Access Environment

Jan Velterop erfreut (und, was wichtiger ist, er läßt uns über die Grundlage unserer Budgets nachdenken) uns mal wieder mit seiner erfrischenden Argumentation (in einer Antwort auf Phil Banks, Cornell University):

I know (don’t need to assume) that not all grant money coming into a university stays in research. The percentages may be different in different circumstances and countries, but at Cornell it is apparently a whopping 58% that doesn’t go to research. Phil argues that that makes redistribution more difficult („we don’t just have reallocation issues to deal with, we have a major shortfall“). I argue that that it makes redistribution potentially easier. A system in which 58% of a grant can be spent on other things than research (including „mowing the law“ [sic] – copyright law?), is a system that should be able to deal with 59% not being spent on research per se. Especially since, after a transition period, the 1-2% of that money which now goes into the library, could be put back into research and compensate for the one percent research loss. That may not even be necessary. Just using low-energy light bulbs throughout the university or turning the heater down a notch in winter and the air condition a degree up in summer may cover the shortfall. Better for the environment anyway. But the more pertinent point is that publishing *is* part of the infrastructure for research. If paying for literature via the library can be an infrastructural provision, then paying for the literature via article charges can be.

I do take the point that researchers may not happily part with money. They are people, after all. They may not happily part with money for lab glassware or chemicals, either. Or with money for mowing the lawn. That’s why we have infrastructural provisions. Publishing is integral to research, and thus the cost of publishing is integral to the cost of research. Those who don’t see it that way should try not publishing their research.

The fact that researchers didn’t like page charges in Phys Rev D ten years ago is neither here nor there. They didn’t get open access for it, they were as aware of the prices of journals as cats are aware of the price of cat food (i.e. not, and they probably couldn’t care less), and it wasn’t an infrastructural provision (which it should have been, even then). They could rightfully see the latter as unfair. After all, researchers don’t have to pay for library subscriptions, either. (Hervorhebungen von mir)

Rethinking How We Provide Bibliographic Services

Die Bibliographic Services Task Force der University of California Libraries hat einen sehr lesenswerten und ehrlichen Bericht erstellt: Rethinking How We Provide Bibliographic Services for the University of California. Zitate:

Our users expect simplicity and immediate reward and Amazon, Google, and iTunes are the standards against which we are judged. Our current systems pale beside them. The current Library catalog is poorly designed for the tasks of finding, discovering, and selecting the growing set of resources available in our libraries.

Users want a rich pool from which to search, simplicity, and satisfaction. One does not have to take a 50-minute instruction session to order from Amazon. Why should libraries continue to be so difficult for our users to master?

Einsparungen durch Open Access?

Jan Velterop schreibt in liblicense zum Übergang auf 100% Open Access: OA wird für stark forschungsorientierte und publizierende Universitäten wie z.B. Cornell teurer als das bisherige Subskriptionsmodell, für eher lehrorientierte Universitäten dagegen deutlich billiger:

Assuming that the total amount of money involved in the aggregate remains the same, redistribution of costs has the important academic and societal benefit of enabling full open access. Given that the funders (mostly governments) inject this money into the system anyway, this could be a winners-only game, the funders, academia, and society as a whole being the winners.

In derselben Post zitiert er die William H. Walters-Studie Institutional Journal Costs in an Open Access Environment:

Because institutional disparities in publishing productivity are far greater than institutional disparities in library holdings, the shift from a subscription-based model to either Open Access model would bring dramatic cost savings (greater than 50%) for most colleges and universities. At the same time, a small number of institutions — the top research universities — would pay a far higher proportion of the total aggregate cost.

Das hatte ich auch schon mal anhand von Nucleic Acid Research berechnet.

Biomedbiblog

Die niederländischen Kollegen van de afdeling Biomedische Informatie (BMI) van de NVB haben seit ein paar Tagen nun auch ihren eigenen Blog (und brauchen nicht immer nach Guus oder Krafty zu schielen). Glückwunsch! Und haben auch schon direkt eine schöne Zusammenstellung von Weblogs gepostet – so führt man sich gleich vernünftig ein.